Personalized treatment for ovarian cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/personalized-treatment-for/id4318482... MD Anderson Cancer Center now has a more strategic approach to treating ovarian cancer which results in a 68% higher rate of removing the whole cancer tumor. Previously, all new ovarian cancer patients would undergo surgery to explore the extent of the disease and remove as much of it as possible. Under this new protocol, all patients undergo this procedure to determine if chemotherapy may...

Prostate Cancer Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/prostate-cancer-moon-shot/id43184821... . The Prostate Cancer Moon Shot at MD Anderson Cancer Center focuses on: reducing overtreatment; combining therapies used in more advanced cases to treat the disease earlier; and developing new, targeted therapies (including immunotherapy) for patients who see little to no benefit from traditional treatment methods. Timothy Thompson, Ph.D., professor in Genitourinary Medical Oncology, discusses...

Lung Cancer Moon Shot update

submitted by: mdanderson
Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderson, talks about new developments in lung cancer research including advances in genetic mapping, molecular profiling, diagnostic imaging and lung cancer screening. With lung cancer being a part of the MD Anderson’s Moon Shots Program, we have a chance to make lung...

Melanoma Moon Shot update 2014

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/melanoma-moon-shot-update/id43184821... . Cases of melanoma and deaths from this form of skin cancer are on the rise. MD Anderson is ideally suited to tackle this growing challenge because of our unparalleled resources and capabilities. Michael Davies, M.D., Ph.D., associate professor of Melanoma Medical Oncology at MD Anderson Cancer Center, discusses the recent advances made in the organization’s Melanoma Moon Shot program.

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Inner workings of StarDrive Propulsion

submitted by: dplews

This video shows the inner workings of StarDrive Mark I and how it creates thrust.

Leukemia (AML/MDS) Moon Shots update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/leukemia-aml-mds-moon-shots/id431848... . Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots,...

Breast and Ovarian Cancers Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/breast-ovarian-cancers-moon/id431848... The moon shot for breast and ovarian cancer focuses on two diseases: triple-negative breast cancer and high-grade serous ovarian cancer. Jennifer Litton, M.D., associate professor of Breast Medical Oncology, and Shannon Westin, M.D., assistant professor of Gynecologic and Reproductive Medicine, discuss several new and exciting projects underway that can quickly make a difference in the...

Melanoma Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Jeffrey Gershenwald, M.D., professor in MD Anderson's...

AML and MDS Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Guillermo Garcia-Manero, M.D., professor in MD Anderson's...